Tumor Volume Doubling Time of Less Than 1 Year Is Associated With a Higher Risk of Death From Medullary Thyroid Cancer
Measurements from 3 baseline and 3 most recent scans preceding follow-up visit enable calculation of TVDT and can be used as predictors of mortality from MTC.
Authors
- Elizabeth C. Wright (ORCID: https://orcid.org/0000-0002-9841-3879)
- John Glod (ORCID: https://orcid.org/0000-0002-3071-7876)
- Ashwin Bharadwaj
- Srivandana Akshintala (ORCID: https://orcid.org/0000-0002-3478-9893)
- Joanna Kłubo-Gwieździńska (ORCID: https://orcid.org/0000-0001-8633-4420)
- C Vikram
- Padmasree Veeraraghavan
- Sriram Gubbi (ORCID: https://orcid.org/0000-0002-9263-1381)
- Anthony Leonardi (ORCID: https://orcid.org/0000-0002-1865-9597)
- Tomilowo Abijo
- Noha Behairy (ORCID: https://orcid.org/0000-0002-3150-7598)
- Mateus Guimarães Pascoal
- Sonam Kumari (ORCID: https://orcid.org/0000-0002-6052-9972)
- Amr Dorgham
- Craig Cochran
Institutions
- National Institutes of Health (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Office of the Director (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1210/clinem/dgae733
- Citations
- 1
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases